์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ
Merck

์ฃผ์š” ๋ฌธ์„œ

๋ชจ๋“  ๋ฌธ์„œ ๋ณด๊ธฐ

๋‹ค์Œ์œผ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ

263427

Sigma-Aldrich

3,5-Bis(trifluoromethyl)phenylacetonitrile

98%

๋กœ๊ทธ์ธ์กฐ์ง ๋ฐ ๊ณ„์•ฝ ๊ฐ€๊ฒฉ ๋ณด๊ธฐ

ํฌ๊ธฐ ์„ ํƒ

500 MG
โ‚น8,998.00
1 G
โ‚น11,924.00
5 G
โ‚น39,149.00

โ‚น8,998.00

๊ตฌ์ž… ๊ฐ€๋Šฅ ์—ฌ๋ถ€๋Š” ๊ณ ๊ฐ์„ผํ„ฐ์— ๋ฌธ์˜ํ•˜์‹ญ์‹œ์˜ค.
๋ฒŒํฌ ๊ฒฌ์  ์š”์ฒญํ•˜๊ธฐ

ํฌ๊ธฐ ์„ ํƒ

๋ณด๊ธฐ ๋ณ€๊ฒฝ
500 MG
โ‚น8,998.00
1 G
โ‚น11,924.00
5 G
โ‚น39,149.00

About This Item

Linear Formula:
(CF3)2C6H3CH2CN
CAS Number:
85068-32-2
Molecular Weight:
253.14
EC Number:
285-294-0
MDL number:
MFCD00009904
UNSPSC ์ฝ”๋“œ:
12352100
PubChem Substance ID:
24855971
NACRES:
NA.22

โ‚น8,998.00

๊ตฌ์ž… ๊ฐ€๋Šฅ ์—ฌ๋ถ€๋Š” ๊ณ ๊ฐ์„ผํ„ฐ์— ๋ฌธ์˜ํ•˜์‹ญ์‹œ์˜ค.
๋ฒŒํฌ ๊ฒฌ์  ์š”์ฒญํ•˜๊ธฐ
๊ธฐ์ˆ  ์„œ๋น„์Šค
๋„์›€์ด ํ•„์š”ํ•˜์‹ ๊ฐ€์š”? ์ €ํฌ ์ˆ™๋ จ๋œ ๊ณผํ•™์ž ํŒ€์ด ๋„์™€๋“œ๋ฆฌ๊ฒ ์Šต๋‹ˆ๋‹ค.
๋„์›€ ๋ฌธ์˜

Quality Level

100

๋ถ„์„

98%

์–‘์‹

liquid

refractive index

n20/D 1.4234 (lit.)

density

1.42 g/mL at 25 ยฐC (lit.)

์ž‘์šฉ๊ธฐ

fluoro
nitrile

SMILES string

FC(F)(F)c1cc(CC#N)cc(c1)C(F)(F)F

InChI

1S/C10H5F6N/c11-9(12,13)7-3-6(1-2-17)4-8(5-7)10(14,15)16/h3-5H,1H2

InChI key

YXGWYBUKRTYHJM-UHFFFAOYSA-N

๊ด€๋ จ ์นดํ…Œ๊ณ ๋ฆฌ

์œ ์‚ฌํ•œ ํ’ˆ๋ชฉ ๋น„๊ต

์ „์ฒด ๋น„๊ต ๋ณด๊ธฐ

์ฐจ์ด์  ํ‘œ์‹œ

1 of 4

์ด ํ’ˆ๋ชฉ
199192232963374857
3,5-Bis(trifluoromethyl)phenylacetonitrile 98%

263427

3,5-Bis(trifluoromethyl)phenylacetonitrile

3-(Trifluoromethyl)phenylacetonitrile 97%

199192

3-(Trifluoromethyl)phenylacetonitrile

4-(Trifluoromethyl)phenylacetonitrile 98%

232963

4-(Trifluoromethyl)phenylacetonitrile

3,5-Bis(trifluoromethyl)phenyl isocyanate 98%

374857

3,5-Bis(trifluoromethyl)phenyl isocyanate

assay

98%

assay

97%

assay

98%

assay

98%

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

refractive index

n20/D 1.4234 (lit.)

refractive index

n20/D 1.4565 (lit.)

refractive index

-

refractive index

n20/D 1.43 (lit.)

form

liquid

form

liquid

form

solid

form

liquid

density

1.42 g/mL at 25 ยฐC (lit.)

density

1.187 g/mL at 25 ยฐC (lit.)

density

-

density

1.476 g/mL at 25 ยฐC (lit.)

functional group

fluoro

functional group

fluoro, nitrile

functional group

fluoro, nitrile

functional group

fluoro, isocyanate

์• ํ”Œ๋ฆฌ์ผ€์ด์…˜

3,5-Bis(trifluoromethyl)phenylacetonitrile may be used in chemical synthesis.

ํ”ฝํ† ๊ทธ๋žจ

Exclamation mark
GHS07

์‹ ํ˜ธ์–ด

Warning

์œ ํ•ด ๋ฐ ์œ„ํ—˜ ์„ฑ๋ช…์„œ

H302 + H312 + H332,H315,H319,H335

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

ํ‘œ์  ๊ธฐ๊ด€

Respiratory system

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point (ยฐF)

235.4 ยฐF - closed cup

Flash Point (ยฐC)

113 ยฐC - closed cup

๊ฐœ์ธ ๋ณดํ˜ธ ์žฅ๋น„

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

  • Specification Sheet

    • ๊ฐ€์žฅ ์ตœ์‹  ๋ฒ„์ „ ์ค‘ ํ•˜๋‚˜๋ฅผ ์„ ํƒํ•˜์„ธ์š”:

    ์‹œํ—˜ ์„ฑ์ ์„œ(COA)

    Lot/Batch Number
    MKCN7089
    MKCJ9811
    MKBK4981V
    MKBL0074V
    MKBH9091V

    ์ ํ•ฉํ•œ ๋ฒ„์ „์„ ์ฐพ์„ ์ˆ˜ ์—†์œผ์‹ ๊ฐ€์š”?

    ํŠน์ • ๋ฒ„์ „์ด ํ•„์š”ํ•œ ๊ฒฝ์šฐ ๋กœํŠธ ๋ฒˆํ˜ธ๋‚˜ ๋ฐฐ์น˜ ๋ฒˆํ˜ธ๋กœ ํŠน์ • ์ธ์ฆ์„œ๋ฅผ ์ฐพ์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

    COA ๊ฒ€์ƒ‰

    ์ด ์ œํ’ˆ์„ ์ด๋ฏธ ๊ฐ€์ง€๊ณ  ๊ณ„์‹ญ๋‹ˆ๊นŒ?

    ๋ฌธ์„œ ๋ผ์ด๋ธŒ๋Ÿฌ๋ฆฌ์—์„œ ์ตœ๊ทผ์— ๊ตฌ๋งคํ•œ ์ œํ’ˆ์— ๋Œ€ํ•œ ๋ฌธ์„œ๋ฅผ ์ฐพ์•„๋ณด์„ธ์š”.

    ๋ฌธ์„œ ๋ผ์ด๋ธŒ๋Ÿฌ๋ฆฌ ๋ฐฉ๋ฌธ

    Naoki Aizawa et al.
    European urology, 62(6), 1165-1173 (2012-09-18)
    Mirabegron is the first ฮฒ3-adrenoceptor agonist that is clinically effective for overactive bladder. The effects of mirabegron on primary bladder mechanosensitive single-unit afferent activities (SAAs) and bladder microcontractions were evaluated and compared with the effects of oxybutynin. Female Sprague-Dawley rats
    P Tauzin-Fin et al.
    Annales francaises d'anesthesie et de reanimation, 31(7-8), 605-608 (2012-07-04)
    Catheter-related bladder discomfort (CRBD) is an unrecognized clinical event. Symptoms of CRBD secondary to an indwelling urinary catheter mimic those of an overactive bladder, i.e. urinary frequency and urgency with or without urge incontinence. Stimulation of muscarinic receptors located in
    R Cremer
    Der Urologe. Ausg. A, 51(7), 991-995 (2012-06-15)
    Paraplegic spina bifida patients often suffer from disturbed sweat secretion in the paretic regions. A diminished sweat production of caudal parts of the body is compensated by an increased secretion of sweat in parts cranial to the lesion to maintain
    Theodore M Johnson et al.
    BJU international, 112(1), 100-108 (2013-03-02)
    WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Nocturia is a common and bothersome lower urinary tract symptom, particularly in men. Many single drug therapies have limited benefit. For men who have persistent nocturia despite alpha-blocker therapy
    Michael H Johnson et al.
    The Journal of urology, 189(4), 1268-1274 (2012-11-06)
    Intravesical bacillus Calmette-Guรฉrin is used to decrease recurrence rates of nonmuscle invasive urothelial carcinoma. Irritative urinary symptoms are a common side effect of treatment and frequently limit treatment tolerance. While anticholinergic medications may be used for symptom prophylaxis, to our
    ๋ชจ๋“  ๊ด€๋ จ๋œ ์„œ๋ฅ˜ ๋ณด๊ธฐ

    ์ž์‚ฌ์˜ ๊ณผํ•™์žํŒ€์€ ์ƒ๋ช… ๊ณผํ•™, ์žฌ๋ฃŒ ๊ณผํ•™, ํ™”ํ•™ ํ•ฉ์„ฑ, ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ, ๋ถ„์„ ๋ฐ ๊ธฐํƒ€ ๋งŽ์€ ์˜์—ญ์„ ํฌํ•จํ•œ ๋ชจ๋“  ๊ณผํ•™ ๋ถ„์•ผ์— ๊ฒฝํ—˜์ด ์žˆ์Šต๋‹ˆ๋‹ค..

    ๊ณ ๊ฐ์ง€์›ํŒ€์œผ๋กœ ์—ฐ๋ฝ๋ฐ”๋ž๋‹ˆ๋‹ค.